scispace - formally typeset
K

Katherine Marsden

Researcher at Royal Hobart Hospital

Publications -  55
Citations -  1236

Katherine Marsden is an academic researcher from Royal Hobart Hospital. The author has contributed to research in topics: Von Willebrand disease & Bone marrow. The author has an hindex of 21, co-authored 54 publications receiving 1137 citations. Previous affiliations of Katherine Marsden include University of Tasmania & Westmead Hospital.

Papers
More filters
Journal ArticleDOI

The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples.

TL;DR: The influence of apixaban and rivaroxaban on haemostasis testing extends beyond routine coagulation assays to encompass a plethora of specialisedAssays, including factor assays, lupus inhibitor, and FVIII inhibitor estimation.
Journal ArticleDOI

Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring

TL;DR: In the hands of patients the CoaguChek XS showed good correlation with laboratory determination of INR and compared well with expanded and narrow clinical agreement criteria.
Journal ArticleDOI

Evaluating errors in the laboratory identification of von Willebrand disease in the real world.

TL;DR: These findings explain the high rate of errors associated with VWD diagnosis and show different VWF assays and activity/antigen ratios show different utility in VWD and type identification.
Journal ArticleDOI

The effect of dabigatran on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples

TL;DR: Findings of haemostasis laboratory tests for one of the DOACs, dabigatran (Pradaxa), tested across a wide range of laboratory assays showed good reproducibility and concordance with expected drug levels assessed by mass spectrometry and were effective to quantify drug levels.
Journal ArticleDOI

Cryopreserved human haematopoietic stem cells retain engraftment potential after extended (5-14 years) cryostorage.

TL;DR: It appears that HSC collections can remain adequate for safe transplantation after up to 14 years of cryostorage, and some precautions may be warranted, namely harvesting higher than normal numbers of HSCs in collections intended for long-term storage and repeating in vitro assays on harvests after long- term storage prior to transplantation.